191
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Risk assessment and experimental design in the development of a prolonged release drug delivery system with paliperidone

, &
Pages 733-746 | Published online: 13 Mar 2017

References

  • YuLXPharmaceutical quality by design: product and process development, understanding and controlPharm Res2008254 781 79118185986
  • PallagiEAmbrusRSzabo-ReveszPCsokaIAdaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulationInt J Pharm2015491 384 39226134895
  • PallagiEKarimiKAmbrusRSzabo-ReveszPCsokaINew aspects of developing a dry powder inhalation formulation applying the quality-by-design approachInt J Pharm2016511 151 16027386791
  • MartoJGouveiaLFGoncalvesLMA quality by design (QbD) approach on starch-based nanocapsules: a promising platform for topical drug deliveryColloids Surf B: Biointerfaces2016143 177 18527003468
  • Fdagov [homepage on the Internet]Guidance for Industry Q8(R2) Pharmaceutical DevelopmentSilver SpringU.S. Department of Health and Human Services Food and Drug Administration2016 [cited October 18, 2016]. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmAccessed October 8, 2016
  • Fdagov [homepage on the Internet]Guidance for Industry Q9 Quality Risk ManagementRockvilleU.S. Department of Health and Human Services Food and Drug Administration2016 [cited October 18, 2016]. Available from: http://www.fda.gov/cder/guidance/index.htmAccessed October 8, 2016
  • IurianSTomuțăIBogdanCDefining the design space for freeze-dried orodispersible tablets with meloxicamDrug Dev Ind Pharm20164212 1977 198927165764
  • AbdulAPoddarSSA flexible technology for modified release of drugs: multi layered tabletsJ Control Release200497 393 40515212872
  • ColomboPBettiniRSantiPPeppasNASwellable matrices for controlled drug delivery: gel-layer behavior, mechanisms and optimal performancePharm Sci Technol Today200036 198 20410840390
  • SzenteVBaskaFZelkoRSuveghKPrediction of the drug release stability of different polymeric matrix tablets containing metronidazoleJ Pharm Biomed Anal201154 730 73421129883
  • ContiSMaggiLSegaleLMatrices containing NaCMC and HPMC 1. Dissolution performance characterizationInt J Pharm2007333 136 14217207943
  • SongSHChaeBRSohnSIFormulation of controlled release pelubiprofen tablet using Kollidon(®) SRInt J Pharm2016511 864 87527492018
  • GrundJKorberMBodmeierRPredictability of drug release from water-insoluble polymeric matrix tabletsEur J Pharm Biopharm201385 650 65523985775
  • SauriJMillanDSune-NegreJMQuality by design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tabletsInt J Pharm2014477 431 44125445523
  • SiepmannFEckartKMaschkeAKolterKSiepmannJModeling drug release from PVAc/PVP matrix tabletsJ Control Release2010141 216 22219737588
  • KumarSRandhawaJKPreparation and characterization of paliperidone loaded solid lipid nanoparticlesColloids Surf B Biointerfaces2013102 562 56823104026
  • AleksovskiALustrikMSibancRDreuRDesign and evaluation of a specific, bi-phase extended release system based on differently coated mini-tabletsEur J Pharm Sci201575 114 12225845632
  • HuangWShiYWangCYuKSunFLiYUsing spray-dried lactose monohydrate in wet granulation method for a low-dose oral formulation of a paliperidone derivativePowder Technol2013246 379 394
  • XuXCostaAPKhanMABurgessDJApplication of quality by design to formulation and processing of protein liposomesInt J Pharm2012434 349 35922683453
  • KaljevicODjurisJDjuricZIbricSApplication of failure mode and effects analysis approach for formulation of carvedilol compression coated tabletsJ Drug Deliv Sci Technol201632 56 63
  • VoraCPatadiaRMittalKMashruRRisk based approach for design and optimization of stomach specific delivery of rifampicinInt J Pharm2013455 169 18123916823
  • ErikssonLJohanssonEKettaneh-WoldNWikstromCWoldSDesign of Experiments Principles and Applications3rd edUmeaUmetrics AB2008
  • GrundJKoerberMWaltherMBodmeierRThe effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tabletsInt J Pharm2014469 94 10124746409
  • RezaMSQuadirMAHaiderSDevelopment of theophylline sustained release dosage form based on Kollidon SRPak J Pharm Sci2002151 63 7016414869
  • TakkaSRajbhandariSSakrAEffect of anionic polymers on the release of propranolol hydrochloride from matrix tabletsEur J Pharm Biopharm200152 75 8211438426
  • LaoLLPeppasNABoeyFYCVenkatramanSSModeling of drug release from bulk-degrading polymersInt J Pharm2011418 28 4121182912
  • NovoaGAGHainamakiJMirzaSPhysical solid-state and dissolution of sustained-release matrices of polyvinylacetateEur J Pharm Biopharm200559 343 35015661507
  • TomutaILeucutaSEThe influence of formulation factors on the kinetic release of metoprolol tartrate from prolong release coated minitabletsDrug Dev Ind Pharm200733 1010 1077
  • PascoalADSMRda SilvaPMCoelho PinheiroMNDrug dissolution profiles from polymeric matrices: data versus numerical solution of the diffusion problem and kinetic modelsInt Commun Heat Mass201561 118 127
  • SiepmannJPeppasNAModeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)Adv Drug Deliv Rev201264 163 174